在心力衰竭类别中,心房的复发后消去:系统性审查和元分析
Carl Hashem1, Jacob Joseph2,3,4, Scott Kinlay4,5,6,7
1Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Cardiology research
|February 3, 2025
概括
导管切除 (CA) 有效地解决心脏衰竭类型中的心房动 (AF):减少 (HFrEF),轻微减少 (HFmrEF) 和保留射出小部分 (HFpEF). 死亡率和住院治疗等长期结果在这些群体中显示出类似的疗效.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭管理的管理
背景情况:
- 之前的研究表明,导管切除 (CA) 减少了心房动 (AF) 复发,死亡率和心力衰竭 (HF) 住院治疗,减少了心脏动 (HFrEF) 和保留了射出分数 (HFpEF).
- 有限的综合数据比较CA疗效和临床结果在HF与轻微减少的射出分数 (HFmrEF) 与HFrEF和HFpEF.
研究的目的:
- 为了确定AF复发,全因死亡率和HF住院的差异,在接受AF切除的HFrEF,HFmrEF和HFpEF患者中确定AF复发,全因死亡率和HF住院的差异.
- 提供对不同HF表型的CA有效性的比较分析.
主要方法:
- 通过PubMed/MEDLINE,Embase和Cochrane图书馆数据库识别的研究的系统审查和元分析.
- 纳入标准包括报告AF复发,死亡率或CA后HF住院的HFrEF,HFmrEF或HFpEF患者的研究.
- 数据分析包括死亡率和HF住院病例的综合危险比率.
主要成果:
- 分析了7项涉及3795名患者的研究 (HFrEF 33.8%,HFmrEF 22.9%,HFpEF 43.3%).
- 在中位数24个月的随访后,在HFrEF (40%),HFmrEF (35%) 和HFpEF (35%) 之间没有观察到AF复发率的显著差异.
- 综合所有原因死亡率和HF住院治疗的风险比率相比保守管理更倾向于切除/节律控制:HFrEF 0.77,HFmrEF 0.81和HFpEF 0.74.
结论:
- 导管切除在解决HFrEF,HFmrEF和HFpEF患者组的AF方面表现出类似的长期疗效.
- 需要进一步的研究来巩固CA对这些HF分类中的全因死亡率的影响.
相关概念视频
01:28Disturbances in Heart Rhythm
884
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
884
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
01:26Heart Failure Drugs: Inotropic Agents
505
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
505
01:22Heart Failure Drugs: β-Blockers
311
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
01:28Mechanism of Cardiac Arrhythmias
882
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
882